Home › Funds › SAPIENT CAPITAL LLC › GILD

SAPIENT CAPITAL LLC position in GILD

GILEAD SCIENCES INC · Health Care

SAPIENT CAPITAL LLC reported holding 164,171 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$24.5M, representing 0.33% of its reported portfolio and ranking #38 among its reported holdings. SAPIENT CAPITAL LLC has disclosed GILD holdings in 10 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)164.17K sh
Reported value held$24.47M
Portfolio Weight0.33%
First reportedQ4 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How SAPIENT CAPITAL LLC's GILD position evolved

SAPIENT CAPITAL LLC first disclosed a stake in GILD in Q4 2023 at 3,086 shares (US$250K). The position peaked in Q3 2026 at 164,171 shares, worth US$24.5M. Across 10 filings, SAPIENT CAPITAL LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 164,171 shares valued at US$24.5M — a reduction of -944 shares quarter over quarter.. Notable position changes include a 7068% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 3.09K $250.00K New
Q3 2024 2.54K $213.12K New
Q4 2024 2.59K $238.87K Add
Q1 2025 185.36K $20.77M Add
Q2 2025 183.16K $20.31M Reduce
Q3 2025 175.08K $19.70M Reduce
Q4 2025 173.35K $21.35M Reduce
Q1 2026 162.83K $22.68M Reduce
Q2 2026 165.12K $20.86M Add
Q3 2026 164.17K $24.47M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has SAPIENT CAPITAL LLC held GILD?

SAPIENT CAPITAL LLC has disclosed GILD holdings in 10 of the last 12 reported quarters, going back to Q4 2023.

What is SAPIENT CAPITAL LLC's current position in GILD?

As of Q3 2026, SAPIENT CAPITAL LLC holds 164.17K shares of GILD (GILEAD SCIENCES INC), valued at $24.47M, representing 0.33% of its reported portfolio and ranking #38.

Has SAPIENT CAPITAL LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), SAPIENT CAPITAL LLC reduced its position in GILD. The position peaked in Q3 2026 at 164.17K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.